Lupin Ltd. | Large-cap | Healthcare
₹1,935.20
0.34%
| Lupin Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 221.9B
Gross Profit 153.5B 69.17%
Operating Income 44.5B 20.04%
Net Income 33.1B 14.90%

Balance Sheet Metrics

Total Assets 292.0B
Total Liabilities 119.1B
Shareholders Equity 172.9B
Debt to Equity 0.69

Cash Flow Metrics

Operating Cash Flow 28.0B
Free Cash Flow 13.2B

Revenue & Profitability Trend

Lupin Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 221.9B 196.6B 162.7B 161.9B 149.3B
Cost of Goods Sold 68.4B 71.5B 72.6B 70.9B 59.2B
Gross Profit 153.5B 125.1B 90.1B 91.0B 90.1B
Operating Expenses 64.0B 51.0B 41.7B 37.9B 34.6B
Operating Income 44.5B 28.0B 8.9B 5.5B 17.4B
Pre-tax Income 40.2B 24.2B 7.2B -13.7B 16.8B
Income Tax 7.1B 4.9B 2.7B 1.4B 4.5B
Net Income 33.1B 19.4B 4.5B -15.1B 12.3B
EPS (Diluted) - ₹41.87 ₹9.41 -₹33.65 ₹26.72

Income Statement Trend

Lupin Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 168.0B 134.5B 124.5B 124.6B 139.9B
Non-Current Assets 124.1B 105.5B 105.0B 93.6B 96.2B
Total Assets 292.0B 240.0B 229.6B 218.2B 236.1B
Liabilities
Current Liabilities 89.6B 85.0B 92.7B 82.8B 84.4B
Non-Current Liabilities 29.5B 11.2B 11.5B 13.2B 13.2B
Total Liabilities 119.1B 96.2B 104.1B 96.0B 97.5B
Equity
Total Shareholders Equity 172.9B 143.7B 125.4B 122.2B 138.6B

Balance Sheet Composition

Lupin Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 40.2B 24.2B 7.2B -13.7B 16.8B
Operating Cash Flow 28.0B 23.5B 10.8B -15.4B 19.4B
Investing Activities
Capital Expenditures -16.5B -9.2B -14.6B 70.9M 62.2M
Investing Cash Flow -43.0B -19.2B -12.8B 28.8B -6.0B
Financing Activities
Dividends Paid -3.7B -1.8B -1.8B -3.0B -2.7B
Financing Cash Flow 21.0B -17.9B -77.5M -13.6B 915.0M
Free Cash Flow 13.2B 27.2B 4.0B -5.4B 11.4B

Cash Flow Trend

Lupin Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 26.88
Forward P/E 23.57
Price to Book 5.11
Price to Sales 3.88
PEG Ratio 23.57

Profitability Ratios

Profit Margin 14.45%
Operating Margin 17.87%
Return on Equity 20.88%
Return on Assets 10.17%

Financial Health

Current Ratio 1.88
Debt to Equity 31.50
Beta 0.31

Per Share Data

EPS (TTM) ₹71.69
Book Value per Share ₹377.02
Revenue per Share ₹497.87

Financial data is updated regularly. All figures are in the company's reporting currency.